Aphria Inc

Most Recent

  • Marijuana field and Aphria logo
    Cannabis

    Why Aphria Looks Like a Good Buy Before the Tilray Merger

    By Mohit Oberoi, CFA
  • Tilray and Aphria logos
    Cannabis

    Latest Tilray and Aphria Merger News: Is It a Done Deal?

    By Mohit Oberoi, CFA
  • Tilray and Aphria logos
    Cannabis

    Tilray or Aphria: Which Stock Should You Buy Before the Merger?

    By Mohit Oberoi, CFA
  • What Cannabis Stocks are Hot
    Cannabis

    Best Cannabis Stocks to Buy Now for 2021

    By Ambrish Shah
  • uploads///Aphrias Short Interest
    Company & Industry Overviews

    Gauging the Bullish-Bearish Sentiment on Aphria

    The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Do CGC, ACB, TLRY, and APHA Look Cheap?

    With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal

    Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.

    By Adam Jones
  • uploads///seedling _
    Company & Industry Overviews

    ACB, APHA, CTST, and HEXO Fall on March 20

    The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.

    By Adam Jones
  • uploads///Forward EV to Sales
    Miscellaneous

    Does Cronos Group Look Expensive Compared to Its Peers?

    Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Markets Rebound but Cannabis Stock Performance Is Mixed

    Markets rebounded today after the recent sell-off fueled by US-China trade tensions.

    By Adam Jones
  • uploads///cannabis
    Cannabis

    Marijuana Movement: Why Do Celebrities Support It?

    Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.

    By Sushree Mohanty
  • uploads///marijuana _
    Company & Industry Overviews

    Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’

    Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.

    By Adam Jones
  • uploads///Trump
    Cannabis

    What Does President Trump Think about Marijuana?

    President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”

    By Sushree Mohanty
  • uploads///cannabis _
    Miscellaneous

    Canaccord Genuity Raises Price Target for Canopy Growth

    On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///Vaping
    Cannabis

    Why Vaping May Not Be a Gold Mine for Cannabis Players

    In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.

    By Sirisha Bhogaraju
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis’s Revenue: Here’s What Analysts Expect

    Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.

    By Sushree Mohanty
  • uploads///Trump
    Cannabis

    Cannabis Industry Heats Up, Trump Might Ban Vaping

    Cannabis legalization is heating up. More states are coming forward to legalize marijuana. Cannabis is also gaining global popularity.

    By Sushree Mohanty
  • uploads///pot stocks
    Cannabis

    Cannabis Investment: How to Buy ACB, CGC, and Other Stocks

    Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis in Mexico: Legalization Bill Is Ready for Voting!

    Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.

    By Sushree Mohanty
  • uploads///Mexico
    Cannabis

    Mexico Will Attempt to Legalize Marijuana in 2020

    Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.

    By Sushree Mohanty
  • uploads///hexo
    Cannabis

    HEXO: Analysts’ Target Price and Ratings

    CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis and Vaping Concerns: Will the Dream Go Up in Smoke?

    Cannabis legalization is a vital topic in the US. Meanwhile, vaping related deaths continue to rise. Will vaping concerns kill the US cannabis dream?

    By Sushree Mohanty
  • uploads///arnel hasanovic oWSXdeASg unsplash
    Cannabis

    Why Canopy Growth Isn’t Happy with Apple

    Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.

    By Sushree Mohanty
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What to Expect from Its Q4 Results

    Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.

    By Sushree Mohanty
  • uploads///south dakota cannabis
    Cannabis

    South Dakota Plans for Marijuana Legalization amid COVID-19

    Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Is Aphria a Good Cannabis Pick for 2020?

    Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis 2.0: Aphria Gets Ready for Edibles Market

    Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.

    By Sushree Mohanty
  • uploads///Cannabis
    Macroeconomic Analysis

    Gundlach Compares Cannabis to Bitcoin

    Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

    By Anuradha Garg
  • uploads///Canna
    Company & Industry Overviews

    Kamala Harris: Presidential Candidate for Legalizing Marijuana

    Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.

    By Adam Jones
  • uploads///canopy growth cannabis
    Cannabis

    Canopy Growth: New Cannabis 2.0 Products amid COVID-19

    Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors’ attention despite all that the marijuana industry has gone through.

    By Sushree Mohanty
  • uploads///Medical cannabis
    Cannabis

    Medical Cannabis in Brazil Is Coming

    According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis Sector 2019 Review and 2020 Outlook

    Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Miscellaneous

    Aurora Cannabis: Analysts’ Target Price after Its Earnings

    Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: South Dakota Does What Trump Said!

    Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.

    By Sushree Mohanty
  • uploads///vaping
    Cannabis

    Vaping Concerns Grow, FDA and FTC Investigate Juul

    Vaping has become very popular. However, investigations by the FTC and FDA sparked more concerns. Juul’s vaping devices could cause seizures.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Aphria: Why Jefferies Recommends a ‘Buy’

    Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.

    By Sushree Mohanty
  • uploads///Canopy
    Cannabis

    Canopy Gets Estimates Revised by Analysts for 2020

    Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Valuation for Cannabis Stocks in October

    The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.

    By Margaret Patrick
  • uploads///Cronos
    Cannabis

    Analysts’ Outlook for Cronos Group in January

    Jefferies reduced the target price for Cronos Group stock to $5.3 from $7.5. The stock’s average target price is set at 12.0 Canadian dollars.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Why Aurora Cannabis Stock and Peers Are Struggling

    Aurora Cannabis (ACB) had a hard time this year. ACB stock had been investors’ favorite in 2018. The stock started off 2019 on a good note

    By Sushree Mohanty
  • uploads///canopy growth pi financial
    Cannabis

    Canopy Growth: Why PI Financial Suggests a ‘Sell’

    Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.

    By Sushree Mohanty
  • uploads///canopy
    Cannabis

    Canopy Growth Gets an Upgrade, Constellation Books Losses

    Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”

    By Sushree Mohanty
  • Cannabis

    Marijuana Legalization: Minnesota Welcomes You!

    Marijuana legalization is an ongoing issue in the US. Currently, the District of Columbia and 11 states have legalized cannabis. Marijuana is still illegal for recreational use in Minnesota. However, the state’s voters might favor legalization. Minnesota voters are ready for marijuana legalization Minnesota hasn’t been able to come up with a legalization decision yet. […]

    By Adam Jones
  • uploads///cann
    Cannabis

    Cannabis Legalization: Is It Time for the US to Act?

    Cannabis legalization has America’s attention. A Gallup survey has shown that two-thirds of Americans want cannabis legalized now.

    By Sushree Mohanty
  • uploads///Opioid
    Cannabis

    Opioid Crisis: Is Cannabis Legalization a Good Idea?

    According to the CDC, about 400,000 people died from opioid overdoses from 1999 to 2017. The number includes deaths from prescription and illegal opioids.

    By Sirisha Bhogaraju
  • uploads///canopy growth buy q
    Cannabis

    Why Canopy Growth Is a ‘Buy’ before Its Earnings

    Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Beverages: Why Canadians Can’t Wait

    Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.

    By Sushree Mohanty
  • uploads///CGC_
    Cannabis

    Why Does Jim Cramer Prefer CGC versus CRON?

    Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.

    By Rajiv Nanjapla
  • uploads///cannabis edibles
    Cannabis

    No Cannabis Edibles in Three Provinces for Christmas

    After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.

    By Sushree Mohanty
  • uploads///ACB
    Cannabis

    Will Aurora Cannabis Turn the Corner in 2020?

    Despite being prepared after Canada legalized recreational cannabis in 2018, Aurora Cannabis struggled to hit its revenue numbers.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Was CGC a Big Mistake for Constellation Brands?

    Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.

    By Margaret Patrick
  • uploads/// Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    How Aurora Cannabis’s Valuations Compare to Its Peers’

    On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.

    By Adam Jones
  • uploads///
    Cannabis

    Cannabis Stocks Up, Broader Equity Market Falls

    Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Legalization: The World Waits for the US

    Cannabis legalization is spreading its roots globally. Considering that other countries are legalizing marijuana, will the US follow suit?

    By Sushree Mohanty
  • uploads///Canopy Growth
    Cannabis

    What’s Canopy Growth Strategy for Growth?

    Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.

    By Sushree Mohanty
  • uploads///IIPR
    Basic Materials

    IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks

    It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: What’s Happening in Utah?

    Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.

    By Sushree Mohanty
  • uploads///illinois cannabis sales
    Cannabis

    Illinois’ Cannabis Sales Soared in June: Which Stocks Will Benefit?

    Cannabis sales have been soaring in all of the US states that classified it as an “essential item” amid the pandemic. Illinois has seen tremendous growth.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Has Irwin Simon Really Turned Aphria Around?

    Aphria (APHA) has impressed investors with its earnings results this year. Overall, the cannabis industry has struggled due to various headwinds.

    By Sushree Mohanty
  • uploads///TJX Sales
    Cannabis

    Aurora Cannabis: Target Price and Valuation Update

    So far, July has been rough for Aurora Cannabis (ACB). The stock has been trending lower ever since the beginning of the month. As of Thursday, the stock has fallen about 17%. However, the stock has delivered a positive return this year. Aurora Cannabis has delivered a positive return of 30% YTD (year-to-date). When we […]

    By Market Realist
  • uploads///Republicans
    Cannabis

    Do Republicans Want to Join the Cannabis Action?

    Republicans have been conservative about cannabis. However, cannabis legalization is a popular discussion topic among Democrats.

    By Sushree Mohanty
  • uploads///marijuana in june
    Cannabis

    Will Marijuana Stocks Continue to Surge in June?

    May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Aphria: Analysts’ Target Price and Ratings

    While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis: Are Its Q4 Results Good or Bad News?

    Aurora Cannabis reported its fourth-quarter results on Wednesday after the market closed. Did the company impress investors?

    By Sushree Mohanty
  • uploads///marijuanaI
    Cannabis

    New Year Will Bring Legal Marijuana to Illinois Residents

    Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.

    By Sushree Mohanty
  • uploads///Bruce Linton
    Cannabis

    Bruce Linton Gives Tips to Canopy’s New CEO

    Bruce Linton, ex-CEO of Canopy Growth (CGC) (WEED), recently had some tips to share with the company’s recently appointed CEO, David Klein.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Why Did Mexico Delay Legalization?

    Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Raymond James Foresees a Cannabis Rebound in 2020

    Cannabis stocks had a difficult 2019. Besides cannabis companies losing out on revenue and profitability, many external factors also affected the sector. While pessimism drove the industry this year, a Raymond James analyst predicts things can turn around in 2020. Let’s take a look. Raymond James feels the cannabis sector could rebound On December 16, […]

    By Sushree Mohanty
  • uploads///seedling _
    Company & Industry Overviews

    The Market Is Sinking and Taking the Cannabis Sector Along

    This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.

    By Adam Jones
  • uploads///Pennsylvania
    Cannabis

    Marijuana Legalization Ramps Up: Is Pennsylvania Next?

    Marijuana legalization is ramping up in the US. Pennsylvania legalized medical cannabis in 2016. Now, the state wants to legalize recreational cannabis.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Analysts Neutral on Aphria’s 2020 Outlook in December

    Aphria has successfully impressed investors compared to other cannabis companies this year, even though the same factors have affected the entire industry.

    By Sushree Mohanty
  • uploads///ACB_
    Cannabis

    Aurora Cannabis Releases Update on Cannabis 2.0

    Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.

    By Rajiv Nanjapla
  • uploads///CRON_
    Cannabis

    Cronos Group Receives Rare ‘Buy’ Rating from MKM Partners

    MKM Partners analyst Bill Kirk likes Cronos Group’s healthy cash position, strong track record, and its relationship with Altria (NYSE:MO).

    By Rajiv Nanjapla
  • uploads///Does Vaping Cannabis Avoid Cancer Caused by Smoking
    Cannabis

    Vaping Cannabis or Smoking Tobacco: Burning Questions

    During its latest earnings call, Aphria (APHA) stated that vapes and concentrates could form a major share of Canada’s recreational market by 2021.

    By Adam Jones
  • uploads///Vaping
    Cannabis

    Vaping Risks: Health Canada’s Warning, US Reports More Cases

    Health Canada issued a statement warning people about vaping risks. There have been more illnesses, possibly caused by vaping, in several US states.

    By Sirisha Bhogaraju
  • uploads///cannabis
    Company & Industry Overviews

    Cannabis Stocks: Will Tough Times End Soon?

    Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis: Will Top Companies’ Earnings Be a Relief?

    The cannabis earnings season has started again. Earnings season is an exciting time for investors who have been eyeing the sector.

    By Sushree Mohanty
  • uploads///mexico
    Cannabis

    Will Mexico Legalize Cannabis by the End of the Month?

    With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

    By Rajiv Nanjapla
  • uploads///canopy growth
    Cannabis

    Why Canopy Growth Acquired BioSteel Sports Nutrition

    On October 2, Canopy Growth (CGC) announced its purchase of a 72% stake in BioSteel Sports Nutrition. CGC stock closed with a gain of 1.6% yesterday.

    By Sushree Mohanty
  • uploads///Canopy Growth_
    Cannabis

    When Will Canopy Growth Become Profitable?

    Canopy Growth reported a negative EBITDA of 92.1 million Canadian dollars in the first quarter of fiscal 2020. The EBITDA fell 69.2% in the second quarter.

    By Rajiv Nanjapla
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    How Cannabis Retail’s First Year Shook Out

    Recreational cannabis has been legally available to Canadians since October 2018, when Canada legalized it. Recently, the country rolled out Cannabis 2.0.

    By Sushree Mohanty
  • uploads///MedMen
    Cannabis

    MedMen: Analysts’ Views before Its Earnings

    MedMen’s disappointing fourth-quarter results caused the stock price to fall. The company missed analysts’ revenue estimates for the quarter.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Are Cannabis Edibles Coming to Maryland Soon?

    Recreational cannabis isn’t legal in Maryland, but the state has been trying to launch edibles as part of its medical marijuana program.

    By Sushree Mohanty
  • uploads///Can_ceo
    Cannabis

    Why Canopy Growth’s New CEO Popped the Stock

    Yesterday, Canopy Growth (CGC) (WEED) announced that it appointed Constellation Brands’ (STZ) CFO David Klein as its new CEO.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Raymond James Is Cautiously Optimistic about Cannabis Stocks

    So far, cannabis stocks have rebounded in 2020, which investors expected. The marijuana industry struggled in 2019. Overall, the rebound will take time.

    By Sushree Mohanty
  • uploads///Hexo
    Cannabis

    Will Hexo Continue to Struggle in 2020?

    For the second quarter of fiscal 2020, analysts expect Hexo’s revenue to grow 25.5% YoY (year-over-year) to 16.8 million Canadian dollars.

    By Sushree Mohanty
  • uploads///canopy_
    Cannabis

    What’s Canopy Growth’s First & Free Brand About?

    Yesterday, BNB Bloomberg reported that Canopy Growth (CGC) (WEED) had officially entered the US CBD market with its First & Free brand.

    By Rajiv Nanjapla
  • uploads///cannabis sales
    Cannabis

    Cannabis Sales Decline Across Canada—Why?

    In October, Canada completed the second phase of recreational cannabis legalization. This was expected to help drive sales. But that hasn’t been the case.

    By Sushree Mohanty
  • uploads///organigram health canada license
    Cannabis

    OrganiGram Receives Expansion License from Health Canada

    On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.

    By Rajiv Nanjapla
  • uploads///Jim Cramer
    Cannabis

    Why Does Jim Cramer Like Cronos Group and Aphria?

    Cronos Group and Aphria are Jim Cramer’s top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors’ faith in the sector.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Corruption in the US: Trouble before Elections?

    Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn’t been much discussion about federal legalization.

    By Sushree Mohanty
  • when does aphria report earnings
    Cannabis

    Aphria’s Upcoming Earnings, Analysts Recommend a Buy

    By Ambrish Shah
  • uploads///Marijuana
    Cannabis

    Vermont Could See Marijuana Sales in 2020

    Marijuana is legal in Vermont for medical and recreational use. However, there are some limitations. The state doesn’t allow marijuana sales yet.

    By Sushree Mohanty
  • uploads///Marijuana
    Cannabis

    Marijuana Sales Soar amid Coronavirus Pandemic

    Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.

    By Sushree Mohanty
  • uploads///aurora cannabis q results announce
    Cannabis

    Aurora Cannabis: Q3 Revenue Beat the Estimates

    Aurora Cannabis saw less of an impact from COVID-19 in the third quarter. Cannabis is an essential item amid the pandemic.

    By Sushree Mohanty
  • uploads///marijuana montana
    Cannabis

    Marijuana Legalization Proceeds in Montana amid COVID-19

    New Approach Montana resumed its marijuana legalization campaign in May. The group submitted plenty of signatures and qualified for the November ballot.

    By Sushree Mohanty
  • uploads///organigram analysts revise
    Cannabis

    OrganiGram Stock Falls after Disappointing Q3 Earnings

    Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.

    By Rajiv Nanjapla
  • uploads///aurora cannabis new cco
    Cannabis

    Aurora Cannabis Appoints New Chief Commercial Officer

    As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.

    By Rajiv Nanjapla
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.